Clinical Trial Update: Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating roxadustat (FG-4592) to correct anemia in newly initiated dialysis patients not treated with ESAs; study completed with posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Dialysis-related Anemia

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Kyntra Bio | Conditions: Dialysis, Anemia | Phase 2 | Status: COMPLETED | Results posted: 2021-10-01